uniQure N.V. Cash Flow Statement
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 22.73 +0.62%
uniQure N.V. free cash flow
In fiscal 2025, uniQure N.V. generated -$178.0 million of operating cash flow and spent $439,000 on capital expenditures. That left free cash flow of -$178.4 million, a free-cash-flow margin of -1108.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
uniQure N.V. cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -198.97M | -239.56M | -308.48M | -126.79M | 329.59M | -125.02M | -124.20M | -83.30M | -79.26M | -73.37M |
| Net Income growth (YoY) | — | — | — | -138.47% | — | — | — | — | — | — |
| Depreciation & Amortization | 14.76M | 12.64M | 11.90M | 8.54M | 7.30M | 10.65M | 6.67M | 12.41M | 7.54M | 5.50M |
| Stock-Based Compensation | 17.68M | 22.26M | 35.09M | 34.20M | 25.64M | 21.83M | 17.53M | 10.71M | 10.28M | 6.21M |
| Change in Working Capital | -2.67M | 3.94M | -10.91M | 2.31M | -727.00K | -36.34M | -3.35M | -7.40M | -22.75M | -4.87M |
| Operating Cash Flow | -177.96M | -182.73M | -145.93M | -145.06M | 287.96M | -134.83M | -98.68M | -76.04M | -64.27M | -72.19M |
| Capital Expenditures | -439.00K | -3.37M | -7.15M | -17.69M | -17.44M | -7.27M | -5.65M | -2.38M | -4.46M | -15.29M |
| Investing Cash Flow | -321.62M | 162.97M | -205.69M | -182.73M | -67.39M | -9.48M | -6.65M | -4.25M | -5.58M | -17.17M |
| Debt Issued | — | — | — | — | 64.07M | — | — | 14.78M | — | — |
| Debt Repaid | — | -53.05M | — | — | -1.57M | — | — | — | — | — |
| Financing Cash Flow | 415.40M | -59.49M | 362.72M | 1.45M | 94.86M | 7.44M | 248.82M | 157.96M | 90.07M | 2.44M |
| Net Change in Cash | -78.53M | -84.22M | 13.37M | -328.18M | 311.67M | -133.05M | 143.38M | 75.49M | 27.53M | -88.55M |
| Free Cash Flow | -178.40M | -186.10M | -153.08M | -162.75M | 270.52M | -142.10M | -104.33M | -78.42M | -68.73M | -87.48M |
This table shows 10 annual periods of uniQure N.V.'s cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow QURE's reporting calendar. What is a cash flow statement?